Skip to main content
. 2016 Nov 7;7:416. doi: 10.3389/fphar.2016.00416

FIGURE 1.

FIGURE 1

Cell viability assay after 4c compound treatment in hematological malignancies. Viability of three healthy donors-peripheral blood mononuclear cells (HD-PBMCs) (A), six lymphoid (B), and five myeloid (C) cell lines was evaluated by MTS assay after treatment with 4c compound at different concentration (1, 5, 10, and 15 μM) for 24, 48, and 72 h. Results are expressed as percent of cell viability normalized to DMSO-treated control cells. The bar-graphs represent mean with SD from three independent experiments.